Related Experiment Video
Updated: Feb 10, 2026

Assaying Proteasomal Degradation in a Cell-free System in Plants
Published on: March 26, 2014
PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal
Yunhai Li1, Jing Huang2, Beilei Zeng3
1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Abstract:
Alterations in the ubiquitin-proteasome system (UPS) and UPS-associated proteins have been implicated in the development of many human malignancies. In this study, we investigated the expression profiles of 797 UPS-related genes using HiSeq data from The Cancer Genome Atlas and identified that PSMD2 was markedly upregulated in breast cancer. High PSMD2 expression was significantly correlated with poor prognosis. Gene set enrichment analysis revealed that transcriptome signatures involving proliferation, cell cycle, and apoptosis were critically enriched in specimens with elevated PSMD2. Consistently, PSMD2 knockdown inhibited cell proliferation and arrested cell cycle at G0/G1 phase in vitro, as well as suppressed tumor growth in vivo. Rescue assays demonstrated that the cell cycle arrest caused by silencing PSMD2 partially resulted from increased p21 and/or p27. Mechanically, PSMD2 physically interacted with p21 and p27 and mediated their ubiquitin-proteasome degradation with the cooperation of USP14. Notably, intratumor injection of therapeutic PSMD2 small interfering RNA effectively delayed xenograft tumor growth accompanied by p21 and p27 upregulation. These data provide novel insight into the role of PSMD2 in breast cancer and suggest that PSMD2 may be a potential therapeutic target.
Insights
PSMD2 is upregulated in breast cancer, promoting tumor growth by degrading cell cycle inhibitors p21 and p27. Inhibiting PSMD2 with small interfering RNA suppressed tumor growth, suggesting PSMD2 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Alterations in the ubiquitin-proteasome system (UPS) are linked to human cancers.
- The role of specific UPS proteins in breast cancer progression requires further elucidation.
Purpose of the Study:
- To investigate the role of PSMD2, a UPS-associated gene, in breast cancer.
- To explore PSMD2 as a potential therapeutic target for breast cancer.
Main Methods:
- Analysis of The Cancer Genome Atlas (TCGA) HiSeq data for 797 UPS-related genes.
- PSMD2 knockdown in vitro and in vivo models.
- Gene set enrichment analysis.
- Western blotting and rescue assays.
- Intratumor injection of PSMD2 small interfering RNA (siRNA).
Main Results:
- PSMD2 was significantly upregulated in breast cancer, correlating with poor prognosis.
- Elevated PSMD2 expression was associated with signatures of proliferation, cell cycle progression, and apoptosis.
- PSMD2 knockdown inhibited proliferation, induced G0/G1 cell cycle arrest, and suppressed tumor growth.
- PSMD2 interacted with and mediated the degradation of p21 and p27, key cell cycle inhibitors.
- PSMD2 siRNA treatment delayed xenograft tumor growth and increased p21/p27 levels.
Conclusions:
- PSMD2 plays a crucial role in promoting breast cancer progression.
- PSMD2 facilitates cell proliferation and tumor growth by targeting p21 and p27 for degradation.
- PSMD2 represents a promising therapeutic target for breast cancer treatment.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...
Negative Regulator Molecules
What is the Cell Cycle?

